These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 27765859)
1. Modeling Strategies for Quantification of In Vivo Hahn A; Schain M; Erlandsson M; Sjölin P; James GM; Strandberg OT; Hägerström D; Lanzenberger R; Jögi J; Olsson TG; Smith R; Hansson O J Nucl Med; 2017 Apr; 58(4):623-631. PubMed ID: 27765859 [TBL] [Abstract][Full Text] [Related]
2. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology. Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic Evaluation of the Tau PET Radiotracer Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144 [No Abstract] [Full Text] [Related]
4. Kinetic Modeling of the Tau PET Tracer Barret O; Alagille D; Sanabria S; Comley RA; Weimer RM; Borroni E; Mintun M; Seneca N; Papin C; Morley T; Marek K; Seibyl JP; Tamagnan GD; Jennings D J Nucl Med; 2017 Jul; 58(7):1124-1131. PubMed ID: 27908967 [No Abstract] [Full Text] [Related]
5. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging. Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706 [TBL] [Abstract][Full Text] [Related]
6. Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease. Shcherbinin S; Schwarz AJ; Joshi A; Navitsky M; Flitter M; Shankle WR; Devous MD; Mintun MA J Nucl Med; 2016 Oct; 57(10):1535-1542. PubMed ID: 27151986 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [ Guehl NJ; Wooten DW; Yokell DL; Moon SH; Dhaynaut M; Katz S; Moody KA; Gharagouzloo C; Kas A; Johnson KA; El Fakhri G; Normandin MD Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2099-2111. PubMed ID: 31332496 [TBL] [Abstract][Full Text] [Related]
8. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand Betthauser TJ; Cody KA; Zammit MD; Murali D; Converse AK; Barnhart TE; Stone CK; Rowley HA; Johnson SC; Christian BT J Nucl Med; 2019 Jan; 60(1):93-99. PubMed ID: 29777006 [TBL] [Abstract][Full Text] [Related]